Deep Venous Thrombosis

Also known as: Venous Thrombosis, Deep / DVT / Deep venous thrombosis NOS / DVT - not obstetric / Thrombosis venous deep / Deep vein thrombosis NOS / Deep vein thrombosis

DrugDrug NameDrug Description
DB06695Dabigatran etexilateDabigatran etexilate is an oral prodrug that is hydrolyzed to the competitive and reversible direct thrombin inhibitor[dabigatran][Label,A177463,A6970]. Dabigatran etexilate may be used to decrease the risk of venous thromboembolic events in patients in whom anticoagulation therapy is indicated[A177463]. In contrast to warfarin, because its anticoagulant effects are predictable, lab monitoring is not necessary[A177463]. Dabigatran etexilate was approved by the FDA in 2010[L6022].
DrugDrug NamePhaseStatusCount
DB01225Enoxaparin0Completed1
DB11728Fondaparinux0Completed1
DB00006Bivalirudin1Completed1
DB01225Enoxaparin1Completed1
DB01225Enoxaparin1 / 2Completed1
DB01225Enoxaparin2Completed1
DB01225Enoxaparin2Recruiting1
DB00945Acetylsalicylic acid2 / 3Unknown Status1
DB06605Apixaban2 / 3Active Not Recruiting1
DB11095Desirudin2 / 3Completed1
DB01109Heparin2 / 3Completed1
DB00682Warfarin2 / 3Active Not Recruiting1
DB06779Dalteparin3Completed1
DB01225Enoxaparin3Recruiting1
DB01109Heparin3Completed2
DB06406Idraparinux3Completed1
DB00946Phenprocoumon3Unknown Status1
DB06228Rivaroxaban3Completed1
DB06822Tinzaparin3Completed1
DB00316Acetaminophen4Completed1
DB06605Apixaban4Recruiting1
DB06779Dalteparin4Recruiting1
DB01225Enoxaparin4Recruiting1
DB01109Heparin4Recruiting1
DB08813Nadroparin4Recruiting1
DB06822Tinzaparin4Recruiting1
DB00682Warfarin4Completed1
DB08813NadroparinNot AvailableCompleted2
DB06228RivaroxabanNot AvailableRecruiting1
DB00682WarfarinNot AvailableRecruiting1
DB00682WarfarinNot AvailableUnknown Status1